Skip to Content

Tag: Rich Dil


Also Noted

InfuSystem sees ‘acceleration’

November 7, 2024HME News Staff

ROCHESTER HILLS, Mich. – InfuSystem Holdings reported revenue of $35.3 million for the third quarter of 2024, an increase of 11% year over year. Of that, Patient Services net revenue was $20.8 million and Device Solutions net revenue was $14.5 million. Adjusted EBITDA was $7.9 million, an increase of 15% year over year. “Our third quarter financial results reflect the forecasted acceleration in our business in the second half of the year,” said Rich Dilorio, CEO. “We saw significant...

Home Infusion Therapy, InfuSystem Holdings, Rich Dil


Read Full Articlered right arrow icon